Acute Investment Advisory’s ProShares Short QQQ PSQ Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q2
Sell
-2,220
Closed -$97.2K 16
2024
Q1
$97.2K Sell
2,220
-230,819
-99% -$10.5M 0.07% 10
2023
Q4
$11M Buy
233,039
+11,288
+5% +$585K 6.53% 6
2023
Q3
$12.1M Buy
221,751
+75,727
+52% +$4.01M 7.25% 5
2023
Q2
$7.72M Buy
146,024
+27,622
+23% +$1.62M 4.64% 9
2023
Q1
$7.21M Buy
118,402
+16,813
+17% +$1.12M 4.72% 7
2022
Q4
$7.48M Buy
101,589
+70,555
+227% +$5.04M 5.1% 6
2022
Q3
$2.31M Buy
+31,034
New +$2.07M 1.66% 15

Other funds holding PSQ

Acute Investment Advisory's PSQ Position: Q2 2024 in Review

Acute Investment Advisory sold out of ProShares Short QQQ (PSQ) in Q2 2024, closing a stake of 2,220 shares — an estimated $97.2K sold.

Acute Investment Advisory first reported a position in PSQ in Q3 2022 and held it in 7 quarters. The position peaked at $12.1M in Q3 2023. 77 funds tracked by Wall St. Rank hold PSQ as of Q2 2024.

  • Acute Investment Advisory reported no remaining ProShares Short QQQ position as of Q2 2024 after selling out during the quarter.
  • Acute Investment Advisory sold 2,220 ProShares Short QQQ shares in Q2 2024, an estimated $97.2K.
  • Acute Investment Advisory first reported a position in ProShares Short QQQ in Q3 2022 and held it in 7 quarters.
  • Acute Investment Advisory's ProShares Short QQQ position peaked at $12.1M in Q3 2023.
  • 77 funds tracked by Wall St. Rank held ProShares Short QQQ as of Q2 2024.

Based on Acute Investment Advisory's 13F filing for Q2 2024, filed 18 Jul 2024.